National Minority Quality Forum’s Cancer Staging Initiative launches website to promote early detection of multiple cancers and equitable cancer care
The new #ShiftCancer initiative aligned with Cancer Moonshot is supported by
The mission of the Cancer Stage Shifting Initiative is to move the country from advanced to early stage cancer diagnosis and treatment, improve cancer care, and reduce the incidence of cancer death for all, with a particular focus on equity and underrepresented populations. .
Racial and ethnic minorities suffer disproportionately from cancer. Routine cancer screening tests currently covered by Medicare only detect five types of cancer (lung, breast, cervical, colorectal, and prostate), which means there are no early detection tests for most types of cancer. Although scientific advances in cancer screening have improved patient outcomes regarding quality of life, cancers without screening are more likely to be discovered at later stages in Black, Hispanic, or Native American/Alaskan people. .
“Early cancer detection should be available to everyone, not just those who can afford to pay out of pocket,” said Dr.
One of the goals of the first phase of the Cancer Staging Initiative will be to increase awareness and access to early detection tests for several cancers. Multiple-cancer early detection (MCED) tests are blood tests (also called liquid biopsies) that are designed to identify the presence of cancer for more than one cancer at a time in earlier, more treatable stages. CMDE tests:
Are designed to detect many types of cancers by looking for cancer signals in the blood.
Are designed to complement existing projections.
Use genomic science and machine learning to transform detection.
“Our vision at
Aligned with The White House Cancer Moonshot, the Cancer Stage Shifting Initiative is a coordinated effort that involves advocacy and education, access to clinical research, representative data, improving quality of care, and commitment community focused on early detection and treatment of cancer in underserved areas. populations.
The initiative has a two-pronged approach:
Increase early cancer detection rates through established screening and guidelines
Screen for more than 50 MCED-detectable cancers through clinical development and reimbursement of MCED technologies and ensuring a patient journey to subsequent diagnosis and treatment.
New online hub to advance equitable cancer care for vulnerable communities
The newly launched online hub includes several interactive features designed to increase awareness of cancer disparities, innovation in early detection and treatment, and provide patient and clinician-focused resources to fill gaps in delivery cancer care.
“The Shift Cancer website is an interactive public resource for healthcare professionals, researchers, policy makers and patients to better understand the cost of cancer to vulnerable communities,” said
ShiftCancer.Org hub features include:
Flight Plan to Equity Cancer Timeline Simulator
Interactive simulator with information on the financial impact, survival, and hospitalization rates of late detection of prevalent cancer tumor types.
Information on innovative cancer care, including diagnostic tools and treatment Innovation education video series that highlights innovations aimed at eliminating cancer disparities
Cancer Command Center
Interactive map of areas with high incidence of cancer or at risk of cancer
Patient headquarters including an FAQ center with financial resources, a “Share your story” engagement module, a local cancer organization locator and a cancer screening locator
Clinician Command Center offering registration for Principal Investigator Training, access to Clinical Investigation Site Network registration, and anti-racism/implied bias training resources
Information on breaking news and local actions in support of policies that address barriers to equitable cancer care
For more information, sign up at http://shiftcancer.org/contact/
Contact by email
Read the full story here: https://www.pr.com/press-release/872491
Press release distributed by PR.com
Copyright © 2022 PR.com and its licensors, source